0001209191-22-007065.txt : 20220203
0001209191-22-007065.hdr.sgml : 20220203
20220203195457
ACCESSION NUMBER: 0001209191-22-007065
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220201
FILED AS OF DATE: 20220203
DATE AS OF CHANGE: 20220203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wei Lin
CENTRAL INDEX KEY: 0001872772
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40602
FILM NUMBER: 22590425
MAIL ADDRESS:
STREET 1: C/O ERASCA, INC.
STREET 2: 10835 ROAD TO THE CURE, SUITE 140
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Erasca, Inc.
CENTRAL INDEX KEY: 0001761918
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831217027
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10835 ROAD TO THE CURE, SUITE 140
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 465-6511
MAIL ADDRESS:
STREET 1: 10835 ROAD TO THE CURE, SUITE 140
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-01
0
0001761918
Erasca, Inc.
ERAS
0001872772
Wei Lin
C/O ERASCA, INC.
10835 ROAD TO THE CURE, SUITE 140
SAN DIEGO
CA
92121
0
1
0
0
Chief Medical Officer
Common Stock
2022-02-01
5
J
0
E
1562
11.6025
A
314062
D
Stock Option (Right to Buy)
11.54
2022-02-01
4
A
0
272100
0.00
A
2032-01-31
Common Stock
272100
272100
D
Includes 1,562 shares acquired under the Erasca, Inc. employee stock purchase plan on December 15, 2021.
1/48th of the shares subject to the option vest monthly following February 2, 2022, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
/s/ Ebun S. Garner, Attorney-in-Fact
2022-02-03